Lupkynis

Chemical Namevoclosporin
Dosage FormCapsules (oral; 7.9mg)
Drug ClassInhibitors
SystemCardiovascular
CompanyAurinia Pharma
Approval Year2021

Indication

  • Used in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis.
Last updated on 2/1/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Lupkynis (voclosporin) Prescribing Information2021Aurinia Pharma U.S, Rockville, MD